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Abstract
Purpose of Review Dietary sodium is an important trigger for hypertension and humans show a heterogeneous blood pressure
response to salt intake. The precise mechanisms for this have not been fully explained although renal sodium handling has
traditionally been considered to play a central role.
Recent Findings Animal studies have shown that dietary salt loading results in non-osmotic sodium accumulation via glycos-
aminoglycans and lymphangiogenesis in skin mediated by vascular endothelial growth factor-C, both processes attenuating the
rise in BP. Studies in humans have shown that skin could be a buffer for sodium and that skin sodium could be a marker of
hypertension and salt sensitivity.
Summary Skin sodium storage could represent an additional system influencing the response to salt load and blood pressure in
humans.
Keywords Blood pressure . Salt . Skin . Sodium . VEGF-C
Introduction
Chronically elevated blood pressure, known as hypertension,
represents an imminent global health challenge. Hypertension
is responsible for over 10million deaths annually and is one of
the foremost modifiable risk factors for stroke, heart failure,
ischaemic heart disease and chronic kidney disease [1–3].
Hypertension currently affects nearly one third of the popula-
tion, and its prevalence is increasing worldwide [4]. Despite
this pervasiveness, the precise origins of hypertension remain
unclear, with research primarily focused on the kidney, brain,
heart and blood vessels. Large population studies suggest that
excessive dietary sodium, principally as the chloride salt, is an
important trigger for hypertension, with the kidney considered
to be the main organ regulating the haemodynamic response
to salt intake [5, 6]. In this review, we examine emerging
evidence supporting the role of the skin in sodium
homeostasis and the regulation of blood pressure and novel
extrarenal mechanisms involved in these.
Rethinking the Mechanisms for Salt
Sensitivity of Blood Pressure (SSBP)
Salt sensitivity of blood pressure (SSBP) refers to the physio-
logical trait by which BP of certain individuals exhibits chang-
es parallel to changes in salt intake, while individuals without
this trait are termed salt resistant [7]. SSBP is more common
with greater age, Afro-Caribbean descent and individuals with
hypertension, diabetes mellitus and chronic kidney disease.
The variability in this trait and the mechanisms by which
sodium influences blood pressure are not fully understood
[7, 8]. In the classical Guytonian model, sodium intake in
excess of renal excretory capacity causes an osmotically driv-
en expansion of the extracellular fluid volume. This leads to
an increase in plasma volume, venous return, and cardiac out-
put, which in turn produce a rise in systemic blood pressure
[9]. Thus, in this traditional paradigm, a defect in renal sodium
excretion is the basis for salt sensitivity; conversely, salt-
resistant individuals are protected from salt-induced BP rises
because they can rapidly excrete a salt load without retaining
sodium [10]. Others have expanded on this model, suggesting
that SSBP occurs with a subnormal decrease in renal and
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peripheral vascular resistance in response to a high salt intake,
rather than an increase in sodium retention and cardiac output,
with the kidney maintaining a central role [11].
More recent studies have similarly challenged this view in
humans. Schmidlin and Laffer et al. noted that both salt-
resistant and salt-sensitive normotensive individuals
underwent similar degrees of body sodium retention with
acute dietary salt loading, demonstrating that in salt-resistant
individuals, sodium retention occurred without adverse effects
on BP [12, 13, 14••].These studies revealed that salt-resistant
individuals can adapt to a salt load via vasodilation concom-
itant to increased cardiac output, while this vasodilatory re-
sponse is attenuated those who are in salt sensitive [12, 13,
14••]. In general, these observations refute the view that salt
sensitivity is solely due to deficiencies in renal excretion of
sodium.
A ‘Three-Compartment Model’ of Body
Sodium
Total body water (TBW) has historically been divided into
two compartments, the intracellular fluid (ICF) and the extra-
cellular fluid (ECF), with this latter compartment comprising
the intravascular and interstitial spaces. Total body sodium
(TBNa) has been similarly compartmentalised [15].While in-
tracellular sodium and fluid volume are tightly regulated to
protect cells against detrimental volume changes, the intravas-
cular and interstitial spaces are generally believed to be in
equilibrium.
Following an increase in dietary salt intake, sodium accu-
mulates in the extracellular space. In theory, each 140mmol of
additional sodium must be coupled with the accumulation of
~ 1 l of water in the extracellular fluid to maintain osmolality.
However, four carefully conducted longer-term sodium bal-
ance studies in healthy humans have shown that large amounts
of sodium can accumulate without commensurate water
[16–19]. Of these studies, the Mars 500 study, which investi-
gated sodium metabolism at constant salt intake under con-
trolled conditions for either 105 or 250 days, showed that
sodium is rhythmically stored and released independent of salt
intake, and that BP, body weight and extracellular water were
not coupled to urine sodium excretion as expected [19]. A
further study, which assessed sodium and water excretion in
healthy humans after infusion with hypertonic saline, found
that sodium recovery in the urine was only half of the expected
amount, indicating that some of the infused sodium was
retained in an osmotically inactivated form [20••]. These ob-
servations support the existence of non-osmotic storage of
excess sodium (sodium accumulation without commensurate
water retention) in an additional third compartment, suggest-
ing the existence of ‘extra-renal’ mechanisms for sodium
homeostasis.
The Skin as a ‘Third Compartment’ of Body
Sodium and Relevance to BP
The skin is the largest organ in the human body, comprising
6% of body weight and forming a significant component of
the interstitium [21, 22]. The skin consists of two tissue layers:
the epidermis, the external layer consisting of non-stratified
epithelial cells and the dermis, which consists mainly of con-
nective tissue [22]. The epidermis is approximately 50–
200 μm thick and acts as a physical barrier against microor-
ganisms and water loss, while the dermis is relatively acellu-
lar, comprised of fibroblasts, blood vessels, lymphatics and
nerves in an extracellular matrix of collagen, elastin and gly-
cosaminoglycans [22, 23]. The skin is a rich source of nitric
oxide, a major regulator of vascular tone, containing ten times
the levels in the circulation [24]. Blood flow in the skin is
dynamic, ranging from as low as 1% in cold temperatures to
as high as 60% in erythroderma and heat stress [25, 26••].
These properties of the skin would suggest the potential for
influencing systemic BP [25, 26••].
From as early as 1909, direct chemical measurements indi-
cated that the skin is a depot for sodium, chloride and water,
although the exact relevance of skin electrolytes was not
known [27–30]. In 1978, Ivanova et al. showed that skin so-
dium in white rats increased with dietary salt loading and
observed that this was associated with an increase in sulphated
glycosaminoglycans [31]. Glycosaminoglycans (GAGs) are
linear polysaccharide chains of variable length consisting of
repeating disaccharide units [32, 33]. Due to the presence of
carboxyl and sulphate functional groups on the disaccharide
units, GAGs possess significant negative charge densities ca-
pable of facilitating the non-osmotic storage of sodium in the
interstitium, as described in a recent comprehensive review
[34••]. It should be noted that the skin is not the only place
with high glycosaminoglycan content, and non-osmotic sodi-
um storage can occur elsewhere in the interstitium.
In 2002, Titze et al. first proposed the connection between
skin sodium, GAGs and BP following a series of rat experi-
ments [35–39]. Work by this group revealed that GAG poly-
merisation facilitates osmotically inactive sodium storage in
the skin, enabling skin sodium concentrations to rise as much
as 180–190 mmol/l without commensurate increases in skin
water content. This osmotically inactive sodium storage could
therefore serve as a mechanism for buffering volume and
blood pressure following changes in salt intake [36–39].
Titze et al. calculated that osmotically inactive sodium stor-
age in salt-resistant rats was threefold higher than in salt-
sensitive rats, based on body sodium and body water measure-
ments [35]. They further demonstrated that male rats had a
higher capacity for osmotically inactive skin sodium storage
compared to fertile female rats, while ovariectomised rats had
no capacity for osmotically inactive sodium accumulation
[36]. The above findings led to the conclusion that the skin
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functions a ‘third compartment’ of body sodium, with a dy-
namic capacity for sodium storage and buffering volume and
blood pressure changes with salt intake.
Tissue Macrophages and the Lymphatics
Influence Sodium Balance, Interstitial Volume
and Blood Pressure
In recent years, it has become apparent that cells of the innate
and adaptive immune system play a role in hypertension and
cardiovascular disease [40]. Work in rodent skin has showed
that macrophages mediate an additional adaptive mechanism
that functions during periods of high salt intake (Fig. 1) [38,
39, 41]. Following salt challenge, skin sodium concentration
increased and the resultant hypertonicity caused recruitment
of macrophages which activated tonicity-responsive enhancer
binding protein (TonEBP). TonEBP increased the expression
of vascular endothelial growth factor C (VEGF-C) gene via
autocrine signalling. By mediating VEGF-C, the macrophage
response restructured the interstitial lymphatic network, en-
abling drainage of water and electrolytes from the skin into
the systemic circulation. VEGF-C also and induced expres-
sion of endothelial nitric oxide synthase (eNOS), causing va-
sodilation via nitric oxide (NO) production. These processes
evidently serve to buffer the haemodynamic effects to salt
loading [38]. VEGF-C and TonEBP antagonism and genetic
deletion and consequent disruption of the above pathway
caused salt sensitivity in these rodents [38, 39, 41].
In summary, macrophages exert a homeostatic function in
the skin via TonEBP and VEGF-C, regulating clearance of
osmotically inactive stored salt via cutaneous lymphatic ves-
sels, buffering the haemodynamic response to dietary salt. In
this process, the lymphatics serve as a connection between
skin as a ‘third compartment’ of body sodium and the circu-
lation and this appears to be mediated by VEGF-C.
Recent Evidence for the Role of the Skin
in Sodium Homeostasis and BP Regulation
in Humans
Most of the novel mechanisms described above linking die-
tary salt, skin sodium, and BP were examined in rodent
models. The rest of this review will focus on recent studies
examining skin sodium in humans, its relevance to human
sodium homeostasis and BP regulation and possible mecha-
nisms linking these.
Insights from Sodium MRI of the Skin
in Humans
For over 30 years, the use of 23Na-MRI spectroscopy has
enabled non-invasive in vivo assessment of sodium concen-
trations in human tissue [43]. Recently, researchers have be-
gun using 23Na-MRI spectroscopy to measure sodium in calf
skin and muscle alongside water measurements using tradi-
tional proton MRI [44, 45, 46••, 47, 48, 49••].
Initial experiments showed that skin sodiumwas positively
correlated with age, and that men had higher skin sodium than
women after controlling for both age and BMI [44, 45, 48]. In
cross-sectional studies on normotensives and hypertensives,
Kopp et al. have shown that skin sodium was positively asso-
ciated with BP, patients with refractory hypertension had in-
creased tissue Na+ content compared to controls, and there
was a trend for increased skin sodium in individuals with
hyperaldosteronism [44, 45].
In 2014, Dahlmann et al. investigated the role of the skin as
a sodium buffer using 23Na-MRI in 24 haemodialysis patients
before and after a single dialysis. Skin sodiumwas reduced by
19% following dialysis, and patients with higher serum
VEGF-C levels had better dialytic Na+ removal [46••]. Skin
sodiumwas also higher in haemodialysis patients compared to
healthy controls, and they noted an age-related rise in skin Na+
Fig. 1 A novel extra-renal mechanism for buffering dietary salt. Under
normal conditions, Na+ binds to negatively charged GAGs in the dermal
interstitium, without commensurate water, allowing high concentrations
of Na+ to accumulate in the skin. During salt loading, the Na+-binding
capacity of GAGs is exceeded and interstitial hypertonicity develops.
This leads to an influx of macrophages, which release an osmosensitive
transcription factor (TonEBP). This induces the secretion of VEGF-C in
an autocrine manner, leading to lymphangiogenesis. The enhanced
lymphatic network increases Na+ transport back into the circulation, for
eventual removal by the kidneys, preventing a blood pressure rise with
salt loading (Adapted from Marvar et al. [42]. Illustrated by Gökçen
Ackali)
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which corresponded to a decline in serum VEGF-C. The au-
thors concluded that skin Na+ stores can be mobilised by
haemodialysis, and VEGF-C facilitates Na+ flow between
the interstitium and systemic circulation in humans,
supporting earlier work in rodents [38, 46••]. More recently,
Kopp et al. showed that type 2 diabetics on haemodialysis had
significantly higher skin sodium compared with their non-
diabetic counterparts [50••].
Schneider et al. used Na MRI to investigate the potential
role of skin Na+ as a biomarker for hypertensive target-organ
damage, further demonstrating that skin sodium content pos-
itively correlated with systolic BP and was a strong, indepen-
dent predictor of left ventricular mass (LVM) in 89 partici-
pants with mild renal impairment [49••]. In these patients, skin
sodium was independent of sex, height, SBP and body hydra-
tion as measured by bioimpedence.
In summary, cross-sectional data from 23Na-MRI studies in
humans show that higher skin sodium storage is associated
with higher BP and target organ damage. Skin sodium appears
to be higher in older individuals, hypertensives, haemodialysis
patients and diabetics—all groups previously known to have
the SSBP trait. Skin sodium changes during dialysis support its
role as a buffer for body sodium. VEGF-C appears to determine
skin sodium in humans, potentially via lymphangiogenesis fa-
cilitating the efflux of sodium. Sex-specific differences in skin
Na+ are interesting, but their relevance is currently unclear.
Thus, it can be seen that 23Na MRI has provided important
insights into the relevance of skin Na+ in humans.
Insights from Direct Chemical Analysis
of the Skin Sodium in Humans
Although MRI data were confirmed by direct ashing of human
cadaveric samples, they have not yet been confirmed by direct
chemical analysis of skin electrolytes in humans [44]. In the past
year, two studies have evaluated skin electrolytes in humans
using inductively coupled plasma optical emission spectrometry
(ICP-OES), a highly sensitive analytical tool capable of simulta-
neous multi-elemental determinations down to the sub-parts-per-
billion level [51, 52••, 53••]. Fischereder et al. measured tissue
Na+ and GAG content in skin and arterial samples taken from
renal transplant donors and recipients [52••]. They showed that
skin and arterial Na+ concentration correlatedwithGAG content,
suggesting that interstitial Na+ storage is regulated by GAGs in
humans, and this could function in the buffering of dietary salt.
They also found that skin Na+ correlated well with arterial Na+,
indicating a possible link between the systemic vasculature and
the skin with regard to sodium homeostasis.
We recently assessed skin electrolytes, blood pressure and
plasma VEGF-C in 48 healthy participants (24 men) taking pla-
cebo (70 mmol sodium/day) and slow sodium (200 mmol/day)
for 7 days in a double-blind, randomised, cross-over study
[53••]. Skin Na+, expressed as the ratio Na+:K+, was 8% higher
following the slow sodium phase. Post hoc analysis revealed a
sex-specific effect, whereinmen experienced a significant 11.2%
increase in skin Na+:K+ following the slow sodium phase while
women did not (4%). Women showed a significant increase in
24-h mean arterial blood pressure and body weight with salt
loading while men did not. We concluded that skin sodium in-
creases with dietary salt loading and this may be influenced by
sex. Women showed a trend for less skin Na+ accumulation of
salt loading and greater salt sensitivity of BP, in keeping with
previous studies in rodents showing the skin functions as a buffer
for dietary sodium [35–39]. We hypothesised that the sex differ-
ences observed could be due to sex-specific skin structural dif-
ferences in thickness andGAG content andmen having a greater
capacity for passage of Na+ through the skin than women [54,
55]. In this study, skin Na+:K+ positively correlated with BP and
peripheral vascular resistance (PVR), in support of recent 23Na
MRI data showing a positive correlation between BP and skin
Na+ [45, 49]. This was seen in men only, possibly due to vari-
ability in skin K+ and hence the Na+:K+ ratio with contraceptive
treatment in women [53••]. No significant changes in plasma
VEGF-C were observed between placebo and slow sodium
phases to support a clear involvement of Ton-EBP or VEGF-C
activation in this study.
Potential Mechanisms Linking Skin Sodium
and Blood Pressure
The exact basis for the relationship between skin sodium and BP
is unknown. These parameters could be linked to a common yet
unknown aetiological factor. Alternatively, skin sodium could
mediate changes in haemodynamics either directly or through
other substances. The Ton-EBP-VEGF-C axis has been shown
to mediate BP in dietary salt loading. Several other mechanisms
could explain the link between skin sodium and haemodynamics.
Skin capillary rarefaction, the reduction in the density of
capillaries, and has been associatedwith hypertension [56–58].
Capillary rarefaction is believed to be structural in origin, as-
sociated with either impaired angiogenesis or capillary attrition
and is believed to mediate BP changes by altering PVR [57].
He et al. showed that in hypertensive humans, a modest reduc-
tion in salt intake improves dermal capillary density as
assessed by capillaroscopy [58]. This trend was seen across
different racial groups and suggests that salt intake is linked
to microvascular rarefaction. The exact mechanisms whereby
salt affects the microcirculation remain unclear, with recent
work in rats suggesting that skin sodium accumulation during
high salt intake increases vasoreactivity in the skin [59].
The hypoxia inducible factor (HIF) transcription system, act-
ing via the heterodimeric transcription factors HIF-1α and HIF-
2α, plays a central role in the cellular response to hypoxia [60].
Recent evidence suggests that the HIF-1α:HIF-2α ratio in the
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skin affects synthesis of nitric oxide synthase 2(NOS 2), a key
regulator of vascular tone [61]. HIF-1α and HIF-2a act antago-
nistically—HIF-1a promotes nitric oxide production by
keratinocytes via NOS 2 while HIF-2α promotes keratinocyte
arginase expression and urea production [62]. Cowburn et al.
recently showed that mice with keratinocyte HIF-1α deletion
had increased vascular tone and elevated systemic BP.
Conversely, deletion of HIF-2α activity in keratinocytes resulted
in increased skin NO levels and reduced systemic BP [61]. In
accordance with this, they showed decreased epidermal expres-
sion of HIF-1α and increased epidermal HIF-2α expression in
hypertensive humans correlated significantlywith increasedmean
blood pressure. These findings provide a novel mechanism for
systemic BP regulation by the skin. Recent evidence in rodents
suggests that HIF metabolism may also be influenced by dietary
salt. In the renal medulla dietary salt suppresses HIF prolyl-
hydroxylase 2 (PHD2), which degrades HIF-1α and HIF-2α,
increasing natriuresis [63, 64]. If high salt intake could similarly
alter levels of HIF isomers in the skin, this would potentially
influence PVR. This would need to be explored in further work.
Movement of Dietary Sodium
into the Skin—How and Why Does It Get
There?
To reach the skin, dietary sodiummust first transit through the
intestine, the blood stream and then out into the dermal inter-
stitium (Fig. 2). Sodium absorption across the apical
membrane of enterocytes and colonocytes is broadly facilitat-
ed by three mechanisms: (1) sugar and phosphate co-transport
via SGLT1, GLUT and NaPi2b; (2) electroneutral proton ex-
change via NHE-2, NHE-3, and NHE-8 and (3) passive dif-
fusion via the sodium channel ENaC [65–69]. This latter
mechanism is predominantly localised to the colon.
In contrast, chloride absorption is largely mediated by
paracellular diffusion and apical bicarbonate exchange via
downregulated-in-adenoma (DRA) proteins. This bicarbonate
exchange is coupled toNHE-mediated sodium absorption, effec-
tively marrying Na+/H+ and Cl−/HCO3
− exchange [70].
Intracellular chloride can diffuse out of enterocytes through chlo-
ride channels.
Intracellular sodium is actively pumped across the basolateral
membrane and into the extracellular space by sodium-potassium
ATPases, which export three sodium ions from the cell in ex-
change for two potassium ions. The requisite extracellular potas-
sium concentrations are maintained by diffusion of intracellular
potassium through basolateral potassium channels. After con-
centration in the extracellular space, sodium can diffuse into
the intestinal capillaries for transport throughout the body. It is
not clear whether these various sodium, chloride and potassium
transporters play a role in sodium sensitivity.
What drives sodium out of vasculature and into the skin
specifically is not well understood, and the transit route from
vascular lumen to dermis is likewise speculative. When
transitioning out of the vascular lumen, sodium first encoun-
ters the endothelial glycocalyx. Comprised primarily of hepa-
ran sulphate proteoglycans (HSPGs), this delicate layer varies
Fig. 2 Movement of sodium from the intestinal lumen to the skin. [1]
Intestinal sodium absorption across the apical membrane of enterocytes is
facilitated by (i) Na-H exchange (NHE-2, NHE-3, NHE-8), (ii)
cotransport with sugars and phosphates (SGLT-1, GLUT, NaPi2b) and
(iii) diffusion through endothelial Na channels (ENaC). Chloride
transport occurs via bicarbonate exchange (DRA) and paracellular
diffusion. [2] Intracellular sodium is actively pumped across the basal
membrane of the intestine by Na-K ATPases. [3] Once in the
interstitium, sodium diffuses into the intestinal capillaries for transport
through the vasculature. [4] Sodium can diffuse paracellularly into the
skin under low salt conditions. Consuming excessive amounts of salt can
exaggerate this process by causing damage to the endothelial glycocalyx
and reducing barrier effectiveness
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in thickness from 0.5 to 4.5 μm [71]. The anionic character of
this glycocalyx facilitates smooth red blood cell movement,
inhibits white blood cell adhesion, scavenges oxygen free rad-
icals and can help detect small changes in blood pressure and
trigger a vasodilatory response [71, 72].
Excessive dietary sodium consumption may damage this
glycocalyx and promote sodium ‘leakage’. In vitro experi-
ments have shown that chronic exposure of endothelial cells
to 150 mM sodium decreased glycocalyx HSPGs by 68% and
caused endothelial stiffening [73, 74]. This damaged glycoca-
lyx could facilitate excessive sodium movement into the in-
terstitium via paracellular diffusion and increased exposure to
or increased activation of vascular ENaC channels [75].
Additionally, glycocalyx damage and endothelial stiffening
may increase leucocyte adhesion and infiltration, further dam-
aging the vessel wall [73, 75, 76].
From current data, it is not immediately clear whether the
skin acts as a pre-emptive reservoir for excessive sodium,
removing it from circulation before it can induce adverse car-
diovascular effects, or if the skin functions as an overflow
reservoir once the excessive sodium has caused sufficient vas-
cular damage to ‘leak’ into the surrounding tissue. Regardless,
once in the skin, the positively charged sodium is osmotically
inactivated through association with anionic GAGs. The pres-
ence of high concentrations of sodium can stimulate increased
GAG synthesis, expanding the storage capacity of this osmot-
ically inactive third compartment.
Conclusions and Future Directions
The skin acts as a third compartment for sodium, capable of
non-osmotic sodium storage and mediating a vasodilatory re-
sponse via VEGF-C. This appears to constitute an extra-renal
mechanism controlling blood pressure during high salt intake.
Incorporating this model into the traditional paradigm of so-
dium homeostasis, the skin may act as a buffer as well as a
reservoir for sodium, while the kidney controls sodium excre-
tion and reabsorption, controlling serum osmolality and total
body water. It is conceivable that people predisposed to salt-
sensitive hypertension have defects in the pathways described
above. What is less understood is why skin sodium accumu-
lation with short-term dietary salt loading appears to protect
from a rise in BP rise, but long-term high skin sodium is
associated with higher BP and the propensity for SSBP. A
potential explanation could be that impaired VEGF-C-
induced lymphangiogenesis in these individuals reduces ef-
flux of sodium from the skin to the systemic circulation and
attenuates the vasodilatory response to salt loading. Further
work is needed to explore this and other mechanisms that
could be involved. The exact mechanisms underlying the
movement of dietary sodium from the gut to the vasculature
and the skin are yet unclear. Future challenges include
ascertaining how different antihypertensive agents affect the
distribution of sodium and water between the skin and the
intravascular space and how this system interacts with other
organs that modulate BP like the kidney and brain.
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